Funding tracker

Orakl Oncology raised €30M

€30MRaised
Series AStage
12 Nov 2026Date
-No post found

The round

Amount€30M (About $32.4M)
StageSeries A
Investorsnot stated
What they doAI predicting effective cancer drugs
VerticalHealth and bio
First reportedThursday, 12 November 2026

The announcement on X

We found no announcement from the company on X.

Similar rounds

CompanyStageAmountLeadOn XDate
MirendilDemocratizing frontier AI R&DSeries A$1B-222.2K12 Nov 2026
UFORCEUkrainian defence technology companySeries A$700M-2.6K12 Nov 2026
SE3Spatial intelligence for military dronesSeries A$30M--12 Nov 2026
Hatz AISells AI through MSPsSeries A$24M--12 Nov 2026
NebulyMeasures economic value of enterprise AI agentsSeries A$21M--12 Nov 2026
BiomatterAI-designed custom enzymesSeries A$18M--12 Nov 2026

Next launch

Planning a launch?

Tell us what is launching and when. Thirty minutes is usually enough to know whether we are the right team for it.